PLX Pharma Inc.
Records under this name other than patents PLX Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to PLX Pharma Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,216,150 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,226,892 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,179,104 | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,646,431 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,786,444 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,648,257 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,730,884 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same Formerly held Lapsed on the fee record Ended Aug 15, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 15, 2025 | USPTO record |